Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - February 2013

7th Annual Improving Solubility Conference

26 Feb 2013 - 28 Feb 2013 - Philadelphia, PA, USA

Bookmark and Share

IQPC’s Improving Solubility Conference has become an annual meeting for the scientific community. This year, we will showcase the newest solubility technologies and provide the latest research from established industry leaders in order to provide you with practical, applicable knowledge to effectively improve bioavailability and drug candidate solubility.

The competition in the pharmaceutical market is at an all time high and without solid techniques to drive increased bioavailability of your products, you will be left in the dust. Learn the latest methodologies and technologies to take on this challenge and minimize the time-to-market on your drug pipeline.

Gain access to exclusive case studies on:

•    Approaches to Leverage In-Vitro Data to Hypothesize In-Vivo Data
•    Rational Formulation Design Guided by Biopharmaceutics Modeling and Automated Formulation Screening
•    Designing and Developing Super Saturation Based Drugs
•    Enhancing the In-Vivo Performance Hot-Melt Extrusion
•    Introducing Levitation Technology for the Production of Amorphous Drugs
•    Co-Crystal Development: From Mortar & Pestle to Production
•    Influence of Particle Size on the Ultraviolet Spectrum of Particulate-Containing Solutions
•    Stability Prediction for Amorphous Materials

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos